» Articles » PMID: 20218795

Increased Xanthine Oxidase in the Thalamus and Putamen in Depression

Overview
Publisher Informa Healthcare
Specialty Psychiatry
Date 2010 Mar 12
PMID 20218795
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

A growing body of literature suggests persistent and selective structural changes in the cortico-limbic-thalamic-striatal system in patients with recurrent depressive disorder (DD). Oxidative stress is thought to play a key role in these processes. So far, the main scientific focus has been on antioxidant enzymes in this context. For the first time, this proof of concept study examines the activity of the free radicals producing the enzyme, xanthine oxidase (XO), directly in the cortico-limbic-thalamic-striatal system of patients with recurrent depression. The activity of XO was ascertained in the cortico-limbic-thalamic-striatal regions in post-mortem brain tissue of patients with recurrent depressive episodes and individuals without any neurological or psychiatric history (7/7). We measured the XO activity in following brain areas: hippocampus, regio entorhinalis, thalamus, putamen and caudate nucleus. In this study, we report a significant increase of XO activity in the thalamus and the putamen of patients with depression. Our findings contribute to the growing body of evidence suggesting that oxidative stress plays a pivotal role in certain brain areas in recurrent depressive disorder.

Citing Articles

Medicinal plants and plant-based traditional medicine: Alternative treatments for depression and their potential mechanisms of action.

Remali J, Aizat W Heliyon. 2024; 10(20):e38986.

PMID: 39640650 PMC: 11620067. DOI: 10.1016/j.heliyon.2024.e38986.


Thiol/Disulfide Homeostasis: A Potential New Peripheral Biomarker in Adolescent Depression.

Ozturk M, Ozkan Y, Yalin Sapmaz S, Erdal S, Taneli F, Kandemir H Psychiatry Clin Psychopharmacol. 2024; 34(1):29-37.

PMID: 38883887 PMC: 11177650. DOI: 10.5152/pcp.2024.23744.


Temporal change of serum xanthine oxidase levels and its relation to clinical outcome of severe traumatic brain injury: a prospective cohort study.

Yan T, Shan H, Wang Z, Zou S, Chen Z, Yu W Neurosurg Rev. 2023; 46(1):320.

PMID: 38038775 DOI: 10.1007/s10143-023-02233-8.


Flavonols in Action: Targeting Oxidative Stress and Neuroinflammation in Major Depressive Disorder.

Jazvinscak Jembrek M, Orsolic N, Karlovic D, Peitl V Int J Mol Sci. 2023; 24(8).

PMID: 37108052 PMC: 10138550. DOI: 10.3390/ijms24086888.


Major Depressive Disorder and Oxidative Stress: A Review of Peripheral and Genetic Biomarkers According to Clinical Characteristics and Disease Stages.

Ait Tayeb A, Poinsignon V, Chappell K, Bouligand J, Becquemont L, Verstuyft C Antioxidants (Basel). 2023; 12(4).

PMID: 37107318 PMC: 10135827. DOI: 10.3390/antiox12040942.